Alley EW - Search Results

1

Phase 1 cohort expansion study of LY3023414, a dual PI3K/mTOR inhibitor, in patients with advanced mesothelioma.

Zauderer MG, Alley EW, Bendell J, Capelletto E, Bauer TM, Callies S, Szpurka AM, Kang S, Willard MD, Wacheck V, Varghese AM. Zauderer MG, et al. Among authors: alley ew. Invest New Drugs. 2021 Aug;39(4):1081-1088. doi: 10.1007/s10637-021-01086-6. Epub 2021 Mar 4. Invest New Drugs. 2021. PMID: 33660194 Free PMC article. Clinical Trial.

2

Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial.

Alley EW, Lopez J, Santoro A, Morosky A, Saraf S, Piperdi B, van Brummelen E. Alley EW, et al. Lancet Oncol. 2017 May;18(5):623-630. doi: 10.1016/S1470-2045(17)30169-9. Epub 2017 Mar 11. Lancet Oncol. 2017. PMID: 28291584 Clinical Trial.

3

Meta-Analysis of Survival and Development of a Prognostic Nomogram for Malignant Pleural Mesothelioma Treated with Systemic Chemotherapy.

Kotecha R, Tonse R, Rubens M, Appel H, Albrecht F, Kaywin P, Alley EW, Tom MC, Mehta MP. Kotecha R, et al. Among authors: alley ew. Cancers (Basel). 2021 May 2;13(9):2186. doi: 10.3390/cancers13092186. Cancers (Basel). 2021. PMID: 34063225 Free PMC article. Review.

4

Clinical Response of Live-Attenuated, Listeria monocytogenes Expressing Mesothelin (CRS-207) with Chemotherapy in Patients with Malignant Pleural Mesothelioma.

Hassan R, Alley E, Kindler H, Antonia S, Jahan T, Honarmand S, Nair N, Whiting CC, Enstrom A, Lemmens E, Tsujikawa T, Kumar S, Choe G, Thomas A, McDougall K, Murphy AL, Jaffee E, Coussens LM, Brockstedt DG. Hassan R, et al. Clin Cancer Res. 2019 Oct 1;25(19):5787-5798. doi: 10.1158/1078-0432.CCR-19-0070. Epub 2019 Jul 1. Clin Cancer Res. 2019. PMID: 31263030 Free PMC article. Clinical Trial.

5

Checkpoint inhibitor-induced myocarditis and myasthenia gravis in a recurrent/metastatic thymic carcinoma patient: a case report.

Szuchan C, Elson L, Alley E, Leung K, Camargo AL, Elimimian E, Nahleh Z, Sadler D. Szuchan C, et al. Eur Heart J Case Rep. 2020 Apr 7;4(3):1-8. doi: 10.1093/ehjcr/ytaa051. eCollection 2020 Jun. Eur Heart J Case Rep. 2020. PMID: 32617460 Free PMC article.

6

Effect of immunotherapy on overall survival in limited-stage small cell lung carcinoma: a national cancer database analysis.

Bilani N, Alley E, Elson L, Nahleh Z, Arteta-Bulos R. Bilani N, et al. Ther Adv Med Oncol. 2021 Feb 23;13:1758835920982806. doi: 10.1177/1758835920982806. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 33747146 Free PMC article.

7

Serum soluble mesothelin-related protein (SMRP) and fibulin-3 levels correlate with baseline malignant pleural mesothelioma (MPM) tumor volumes but are not useful as biomarkers of response in an immunotherapy trial.

Katz SI, Roshkovan L, Berger I, Friedberg JS, Alley EW, Simone CB 2nd, Haas AR, Cengel KA, Sterman DH, Albelda SM. Katz SI, et al. Among authors: alley ew. Lung Cancer. 2021 Apr;154:5-12. doi: 10.1016/j.lungcan.2021.01.011. Epub 2021 Jan 14. Lung Cancer. 2021. PMID: 33561782 Clinical Trial.

8

Delayed-Phase Enhancement for Evaluation of Malignant Pleural Mesothelioma on Computed Tomography: A Prospective Cohort Study.

Patel A, Roshkovan L, McNulty S, Alley E, Torigian DA, Nachiappan AC, Galperin-Aizenberg M, Barbosa EM Jr, DiRienzi J, Berger I, Khalid U, Haas AR, Singhal S, Wileyto EP, Cengel KA, Katz SI. Patel A, et al. Clin Lung Cancer. 2021 May;22(3):210-217.e1. doi: 10.1016/j.cllc.2020.06.002. Epub 2020 Jun 14. Clin Lung Cancer. 2021. PMID: 32693945 Free article.

9

Immunotherapy and radiation therapy for malignant pleural mesothelioma.

Alley EW, Katz SI, Cengel KA, Simone CB 2nd. Alley EW, et al. Transl Lung Cancer Res. 2017 Apr;6(2):212-219. doi: 10.21037/tlcr.2017.04.01. Transl Lung Cancer Res. 2017. PMID: 28529903 Free PMC article. Review.

10

Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer: A Phase 2 Trial.

Bauml JM, Mick R, Ciunci C, Aggarwal C, Davis C, Evans T, Deshpande C, Miller L, Patel P, Alley E, Knepley C, Mutale F, Cohen RB, Langer CJ. Bauml JM, et al. JAMA Oncol. 2019 Sep 1;5(9):1283-1290. doi: 10.1001/jamaoncol.2019.1449. JAMA Oncol. 2019. PMID: 31294762 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters